VOYG logo

Voyager Technologies Inc. Class A (VOYG)

$28.76

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on VOYG

Market cap

$1.78B

EPS

-1.54

P/E ratio

--

Price to sales

10.98

Dividend yield

--

Beta

4.419654

Price on VOYG

Previous close

$30.88

Today's open

$30.27

Day's range

$27.91 - $30.35

52 week range

$17.41 - $52.40

Profile about VOYG

CEO

--

Employees

--

Headquarters

Denver, CO

Exchange

New York Stock Exchange

Shares outstanding

61967758

Issue type

Common Stock

VOYG industries and sectors

Industrials

Aerospace & Defense

News on VOYG

Voyager Appoints Patrick Yarborough to Lead Investor Relations

DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) appointed Patrick Yarborough as vice president, Investor Relations, effective immediately, bringing more than a decade of capital markets, investor communications and corporate development experience to the company. “Growing a public company requires growing the market's trust in it,” said Phil De Sousa, chief financial officer, Voyager. “As we scale our capital base and investor footprint, having someone who has sat on both sides of th.

news source

Business Wire • Oct 7, 2026

news preview

Flexcompute Collaborates with Starlab and Voyager on GPU-Native Simulation of Critical Space Station Life Support System

Leading CFD platform provider helps Starlab's life support team model airflow inside the commercial successor to the International Space Station BOSTON, Oct. 6, 2026 /PRNewswire/ -- Flexcompute, the physics company, today announced it is collaborating with Starlab Space and Voyager Technologies (NYSE: VOYG) to simulate cabin airflow inside Starlab, the commercial space station designed to succeed the International Space Station (ISS). On a space station, air does not move on its own.

news source

PRNewsWire • Oct 6, 2026

news preview

Voyager Awarded Cancer Research Mission Management Contract

DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) signed a contract with the Center for the Advancement of Science in Space to manage Symphony Biosciences' biopolymer cancer implant experiment aboard the International Space Station (ISS). The contract underscores the continued demand for access to low-Earth orbit for biopharmaceutical research.“Our mission management service exists to clear the obstacles between breakthrough research and low-Earth orbit,” said Scott Rodriguez, vice pres.

news source

Business Wire • Oct 6, 2026

news preview

Voyager Awarded $22.4M DoW Contract for Next-Gen Satellite Deployment Systems

DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) announced the award of a $22.4 million Other Transaction Agreement (OTA) with the Strategic Capabilities Office (SCO) from the Department of War (DoW) for a Research and Development (R&D) effort to prototype next-generation satellite deployment systems. The effort's ultimate objective is to transition new technology and capability to the U.S. Space Force.“This award reflects Voyager's confidence in our ability to move rapidly from co.

news source

Business Wire • Oct 5, 2026

news preview

Voyager Announces Third Quarter 2026 Earnings Results Call

DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) will host its third quarter 2026 earnings results conference call Tuesday, November 3, 2026, at 9 a.m. ET with the senior management team. Third quarter 2026 results will be published after the market closes Monday, November 2, 2026. A live webcast of the call will be made available on the Events & Presentations section of Voyager's investor relations website at investors.voyagertechnologies.com. The earnings release and presentatio.

news source

Business Wire • Oct 1, 2026

news preview

Anduril and Voyager Establish Strategic Partnership Across Advanced Weapons and Propulsion

DENVER--(BUSINESS WIRE)--Anduril Industries and Voyager Technologies (NYSE: VOYG) announced a strategic partnership to accelerate the development, testing, qualification and production of critical technologies for advanced U.S. weapon systems and missile defense.Anduril and Voyager are already collaborating across multiple strategic weapons programs, including some of the Department of War's highest priority initiatives. To date, Voyager is contracted to supply more than $60 million of critical.

news source

Business Wire • Sep 29, 2026

news preview

Voyager Stock Rises After Formalizing Anduril Partnership

Voyager Technologies Inc. (NYSE:VOYG) shares are trading higher Tuesday after the company announced a strategic partnership with Anduril Industries to accelerate the development, testing and production of advanced weapon systems and missile defense technologies.

news source

Benzinga • Sep 29, 2026

news preview

Voyager Technologies, Inc. Completes $402.5 Million Convertible Senior Notes Offering

DENVER--(BUSINESS WIRE)--Voyager Technologies, Inc. (“Voyager”) (NYSE: VOYG) today announced that it completed its previously announced offering of $402,500,000 aggregate principal amount of 0% convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The $402,500,0000 aggregate principal amount includes $52,500,000 aggregate.

news source

Business Wire • Sep 28, 2026

news preview

Commercial Demand for Microgravity Drug Discovery Accelerates as Exobiosphere and Voyager Add Two Missions to the ISS

DENVER & HOUSTON--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) and Exobiosphere today announced two additional research campaigns aboard the International Space Station, expanding an agreement that is turning commercial biotech research in microgravity into a recurring, schedulable service rather than a one-off opportunity. Exobiosphere's Orbital High-Throughput Screening in Microgravity (OHTS) platform, a mid-deck-locker-class system for automated drug screening, is scheduled for install.

news source

Business Wire • Sep 24, 2026

news preview

Voyager Technologies: A 16% Selloff As Dilution Funds Growth

Voyager Technologies remains a speculative high-risk buy after announcing a $350M convertible notes offering, with capped calls mitigating some dilution. VOYG's growth hinges on scaling Space Solutions, Starlab, and defense segments, requiring significant upfront investments and acceptance of near-term negative cash flows. The convertible notes align with prior debt expectations; potential dilution is estimated at 12–15%, but the share price drop exceeds this dilution.

news source

Seeking Alpha • Sep 24, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Voyager Technologies Inc. Class A

Open an M1 investment account to buy and sell Voyager Technologies Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in VOYG on M1